Skip to main content

Advertisement

ADVERTISEMENT

Videos

edward kaftarian and amber hoberg
Videos
02/09/2022
Amber Hoberg, NP, and Edward Kaftarian, MD, explore what clinicians can learn about their patients during telepsychiatry visits while ensuring confidentiality and adequate privacy.
Amber Hoberg, NP, and Edward Kaftarian, MD, explore what clinicians can learn about their patients during telepsychiatry visits while ensuring confidentiality and adequate privacy.
Amber Hoberg, NP, and Edward...
02/09/2022
Psych Congress Network
Andrew Penn and Heather Flint
Video
02/04/2022
In this video, Psych Congress Steering Committee Member Andrew Penn, MS, PMHNP shares resources and education opportunities for clinicians interested in psychedelic treatments to build a foundation with Heather Flint, senior digital managing...
In this video, Psych Congress Steering Committee Member Andrew Penn, MS, PMHNP shares resources and education opportunities for clinicians interested in psychedelic treatments to build a foundation with Heather Flint, senior digital managing...
In this video, Psych Congress...
02/04/2022
Psych Congress Network

Advertisement

Andrew Penn and Heather Flint
Video
02/04/2022
In this video, Psych Congress Steering Committee Member Andrew Penn, MS, PMHNP shares advice for clinicians interested in psychedelic treatments with Heather Flint, senior digital managing editor, Psych Congress Network.
In this video, Psych Congress Steering Committee Member Andrew Penn, MS, PMHNP shares advice for clinicians interested in psychedelic treatments with Heather Flint, senior digital managing editor, Psych Congress Network.
In this video, Psych Congress...
02/04/2022
Psych Congress Network
Videos
02/04/2022
In this video, Heather Flint, senior digital managing editor, Psych Congress Network, talks with Psych Congress Steering Committee Member Andrew Penn, MS, PMHNP about ketamine-assisted therapy for treatment-resistant mental health disorders.
In this video, Heather Flint, senior digital managing editor, Psych Congress Network, talks with Psych Congress Steering Committee Member Andrew Penn, MS, PMHNP about ketamine-assisted therapy for treatment-resistant mental health disorders.
In this video, Heather Flint,...
02/04/2022
Psych Congress Network
Videos
02/03/2022
Psych Congress Steering Committee Member Andrew Penn, MS, PMHNP, discusses the history of psychedelic treatments and psychedelic treatment for treatment-resistant mental health disorders.
Psych Congress Steering Committee Member Andrew Penn, MS, PMHNP, discusses the history of psychedelic treatments and psychedelic treatment for treatment-resistant mental health disorders.
Psych Congress Steering...
02/03/2022
Psych Congress Network

Advertisement

Laptop computer
Videos
02/03/2022
Michael J Verbora, MD, MBA, asks Ben Medrano, MD, to share educational resources such as training, conferences, and institutions for clinicians seeking to learn more about getting involved with psychedelic treatment options.
Michael J Verbora, MD, MBA, asks Ben Medrano, MD, to share educational resources such as training, conferences, and institutions for clinicians seeking to learn more about getting involved with psychedelic treatment options.
Michael J Verbora, MD, MBA, asks...
02/03/2022
Psych Congress Network
cannabis
Videos
02/03/2022
Michael J Verbora, MD, MBA, and Ben Medrano, MD, discuss whether psychedelics will be used in a nonmedical context, future research, and lessons learned from the cannabis industry including it being an alternative to opiates.
Michael J Verbora, MD, MBA, and Ben Medrano, MD, discuss whether psychedelics will be used in a nonmedical context, future research, and lessons learned from the cannabis industry including it being an alternative to opiates.
Michael J Verbora, MD, MBA, and...
02/03/2022
Psych Congress Network
trauma depression anxiety
Videos
02/03/2022
Michael J Verbora, MD, MBA, asks Ben Medrano, MD to explain ketamine-assisted psychotherapy [KAP] implementation and the experiences patients have had with the treatment.
Michael J Verbora, MD, MBA, asks Ben Medrano, MD to explain ketamine-assisted psychotherapy [KAP] implementation and the experiences patients have had with the treatment.
Michael J Verbora, MD, MBA, asks...
02/03/2022
Psych Congress Network

Advertisement

bipolar graphic
Videos
02/03/2022
Ben Medrano, MD, and Michael J Verbora, MD, MBA discuss what patient populations are benefiting most from intravenous (IV) ketamine treatment and what populations could be potentially harmed by the treatment.
Ben Medrano, MD, and Michael J Verbora, MD, MBA discuss what patient populations are benefiting most from intravenous (IV) ketamine treatment and what populations could be potentially harmed by the treatment.
Ben Medrano, MD, and Michael J...
02/03/2022
Psych Congress Network
Charles Raison
Videos
02/02/2022
Charles Raison, MD, discusses the history, pharmacology, and clinical potential of the lesser-known psychedelics, including Ibogain, 5-MeO-DMT, LSD, and DMT.
Charles Raison, MD, discusses the history, pharmacology, and clinical potential of the lesser-known psychedelics, including Ibogain, 5-MeO-DMT, LSD, and DMT.
Charles Raison, MD, discusses...
02/02/2022
Psych Congress Network

Advertisement